Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 10358

1.

Bile acids promote gastric intestinal metaplasia by upregulating CDX2 and MUC2 expression via the FXR/NF-κB signalling pathway.

Yu JH, Zheng JB, Qi J, Yang K, Wu YH, Wang K, Wang CB, Sun XJ.

Int J Oncol. 2019 Mar;54(3):879-892. doi: 10.3892/ijo.2019.4692. Epub 2019 Jan 22.

2.

Sorafenib/MEK inhibitor combination inhibits tumor growth and the Wnt/β‑catenin pathway in xenograft models of hepatocellular carcinoma.

Huynh H, Ong R, Goh KY, Lee LY, Puehler F, Scholz A, Politz O, Mumberg D, Ziegelbauer K.

Int J Oncol. 2019 Mar;54(3):1123-1133. doi: 10.3892/ijo.2019.4693. Epub 2019 Jan 23.

PMID:
30747223
3.

lncRNA H19 promotes viability and epithelial-mesenchymal transition of lung adenocarcinoma cells by targeting miR-29b-3p and modifying STAT3.

Liu L, Liu L, Lu S.

Int J Oncol. 2019 Mar;54(3):929-941. doi: 10.3892/ijo.2019.4695. Epub 2019 Jan 24.

4.

MACC1 overexpression in carcinoma‑associated fibroblasts induces the invasion of lung adenocarcinoma cells via paracrine signaling.

Li Z, Guo T, Fang L, Li N, Wang X, Wang P, Zhao S, Li F, Cui Y, Shu X, Zhao L, Li J, Gu C.

Int J Oncol. 2019 Jan 30. doi: 10.3892/ijo.2019.4702. [Epub ahead of print]

PMID:
30720137
5.

Long non-coding RNA TUG1 recruits miR‑29c‑3p from its target gene RGS1 to promote proliferation and metastasis of melanoma cells.

Wang Y, Liu G, Ren L, Wang K, Liu A.

Int J Oncol. 2019 Jan 28. doi: 10.3892/ijo.2019.4699. [Epub ahead of print]

PMID:
30720136
6.

A novel mechanism for the anticancer activity of aspirin and salicylates.

Bashir AIJ, Kankipati CS, Jones S, Newman RM, Safrany ST, Perry CJ, Nicholl ID.

Int J Oncol. 2019 Jan 29. doi: 10.3892/ijo.2019.4701. [Epub ahead of print]

PMID:
30720135
7.

Triacetyl resveratrol upregulates miRNA‑200 and suppresses the Shh pathway in pancreatic cancer: A potential therapeutic agent.

Fu J, Shrivastava A, Shrivastava SK, Srivastava RK, Shankar S.

Int J Oncol. 2019 Jan 28. doi: 10.3892/ijo.2019.4700. [Epub ahead of print]

PMID:
30720134
8.

Upregulation of microRNA‑194‑5p inhibits hypopharyngeal carcinoma cell proliferation, migration and invasion by targeting SMURF1 via the mTOR signaling pathway.

Xu S, Hui L, Yang N, Wang Y, Zhao N, Jiang XJ.

Int J Oncol. 2019 Feb 4. doi: 10.3892/ijo.2019.4711. [Epub ahead of print]

PMID:
30720112
9.

Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first‑line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study.

Chibaudel B, Bachet JB, André T, Auby D, Desramé J, Deplanque G, Lecaille C, Louvet C, Tournigand C, Lebrun-Ly V, Dauba J, Lledo G, Garcia ML, Dubreuil O, Hamed NB, Meurisse A, Larsen AK, Tijeras-Raballand A, Bonnetain F, De Gramont A.

Int J Oncol. 2019 Feb 1. doi: 10.3892/ijo.2019.4709. [Epub ahead of print]

PMID:
30720091
10.

Downregulation of protein disulfide‑isomerase A3 expression inhibits cell proliferation and induces apoptosis through STAT3 signaling in hepatocellular carcinoma.

Kondo R, Ishino K, Wada R, Takata H, Peng WX, Kudo M, Kure S, Kaneya Y, Taniai N, Yoshida H, Naito Z.

Int J Oncol. 2019 Feb 4. doi: 10.3892/ijo.2019.4710. [Epub ahead of print]

PMID:
30720090
11.

Lysyl oxidase assists tumor‑initiating cells to enhance angiogenesis in hepatocellular carcinoma.

Yang M, Liu J, Wang F, Tian Z, Ma B, Li Z, Wang B, Zhao W.

Int J Oncol. 2019 Jan 31. doi: 10.3892/ijo.2019.4705. [Epub ahead of print]

PMID:
30720077
12.

Glyceryl trinitrate‑induced cytotoxicity of docetaxel‑resistant prostatic cancer cells is associated with differential regulation of clusterin.

Bouaouiche S, Magadoux L, Dondaine L, Reveneau S, Isambert N, Bettaieb A, Jeannin JF, Laurens V, Plenchette S.

Int J Oncol. 2019 Feb 1. doi: 10.3892/ijo.2019.4708. [Epub ahead of print]

PMID:
30720069
13.

lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma.

Chen F, Qi S, Zhang X, Wu J, Yang X, Wang R.

Int J Oncol. 2019 Feb 1. doi: 10.3892/ijo.2019.4707. [Epub ahead of print]

PMID:
30720068
14.
15.
16.

Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling.

Lu CC, Chiang JH, Tsai FJ, Hsu YM, Juan YN, Yang JS, Chiu HY.

Int J Oncol. 2019 Jan 30. doi: 10.3892/ijo.2019.4704. [Epub ahead of print]

PMID:
30720062
17.

Partial agonistic effect of cetuximab on epidermal growth factor receptor and Src kinase activation in triple‑negative breast cancer cell lines.

Gurdal H, Tuglu MM, Bostanabad SY, Dalkiliç B.

Int J Oncol. 2019 Jan 28. doi: 10.3892/ijo.2019.4697. [Epub ahead of print]

PMID:
30720056
18.

Mitochondrial calcium: Transport and modulation of cellular processes in homeostasis and cancer (Review).

Romero-Garcia S, Prado-Garcia H.

Int J Oncol. 2019 Jan 28. doi: 10.3892/ijo.2019.4696. [Epub ahead of print]

PMID:
30720054
19.

[Corrigendum] miR‑122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3.

Nie W, Ni D, Ma X, Zhang Y, Gao Y, Peng C, Zhang X.

Int J Oncol. 2019 Jan 23. doi: 10.3892/ijo.2019.4694. [Epub ahead of print]

PMID:
30720052
20.

RBM3 upregulates ARPC2 by binding the 3'UTR and contributes to breast cancer progression.

Chen P, Yue X, Xiong H, Lu X, Ji Z.

Int J Oncol. 2019 Jan 28. doi: 10.3892/ijo.2019.4698. [Epub ahead of print]

PMID:
30720048

Supplemental Content

Loading ...
Support Center